News
-
Mounjaro reduces T2 diabetes risk: study
Friday | Nov 15 2024ELI Lilly has announced that The New England Journal of Medicine has published the results of the Phase 3 SURMOUNT-1 study, the longest study of the weight loss drug Mounjaro (tirzepatide) to date.
-
Dispensary Corner 15 Nov 24
Friday | Nov 15 2024IN A surprising twist, attending daycare might just lower the risk of type 1 diabetes in kids.
-
PharmX and CH2 position for growth
Thursday | Nov 14 2024PHARMACY ordering platform PharmX has expanded its partnership with CH2, a Community Service Obligation wholesaler and part of Paragon Care Limited.
-
Rural research suffering
Thursday | Nov 14 2024A RECENT audit by the Federal Department of Health and Aged Care has highlighted the need to strengthen support for health and medical research professionals in rural, regional, and remote areas.
-
Cost of managing diabetes too high
Thursday | Nov 14 2024ON WORLD Diabetes Day today, Diabetes Australia released alarming data showing that cost-of-living pressures are heavily impacting Australians with the disease, putting their health at serious risk.
-
Consider savings
Thursday | Nov 14 2024WHETHER it is catalogue pre-order rebates, dispensary assistance subscriptions or bonus stock, aligning with Chemsave delivers bottom-line benefits - learn more about a special offer on page five.
-
Limited-time offer
Thursday | Nov 14 2024NOVA Pharmaceuticals is offering a special pharmacy deal on Proctocaine haemorrhoid relief ointment.
-
PSA highlights breadth of impactful work
Thursday | Nov 14 2024THE Pharmaceutical Society of Australia (PSA) released its 2024 Impact Report today, highlighting its efforts in advancing the Quality Use of Medicines.
-
Editor’s Choice: Smart, portable melts for faster absorption
Thursday | Nov 14 2024SWISSE has introduced a line of Ultiboost Smart Melt supplements, designed for quick, on-the-go support in a format that dissolves on the tongue, with no water required.
-
Weleda’s B Corp boost
Thursday | Nov 14 2024WELEDA, a global company for natural cosmetics and anthroposophic medicines, has successfully completed its B Corp recertification with an improved score of 120.66, a 13% rise from its initial 2021 certification.
